Marty McCary

Dr. Marty McCary, FDA Commissioner and a seasoned contributor, delves into groundbreaking discussions on autism research and FDA policy. He shares insights on a new link between acetaminophen during pregnancy and autism risk, shedding light on important study findings. Dr. McCary also highlights innovative treatments involving leucovorin for autistic children and emphasizes his aims for the FDA, including speeding up drug approvals and improving children's nutrition. Additionally, he addresses reforming sunscreen regulations to enhance safety.

Marty McCary is a renowned surgeon and public policy researcher, while Cara Anthony investigates trauma and violence as a reporter, and Rachel Yehuda is a distinguished professor studying intergenerational trauma. They discuss how outdated medical guidelines on peanut allergies led to unintended consequences and highlight the shocking legacy of trauma within communities, particularly among descendants of Holocaust survivors. The conversation dives into the importance of understanding these ripple effects for better health outcomes and emotional healing.

In this insightful discussion, former President Donald Trump emphasizes the need for reduced acetaminophen use during pregnancy and advocates for revised vaccine schedules in autism policy. Robert F. Kennedy Jr. critiques prior NIH studies on autism, proposing a fresh exposomics-driven approach to uncovering its causes. Dr. Marty McCary outlines FDA initiatives, including updates to acetaminophen labeling and new therapies for children with autism, sparking a vital conversation on the environmental triggers vs. diagnostic changes in the autism epidemic.